The COVID-19 vaccine development landscape

Saved in:
Bibliographic Details
Published inNature reviews. Drug discovery Vol. 19; no. 5; pp. 305 - 306
Main Authors Thanh Le, Tung, Andreadakis, Zacharias, Kumar, Arun, Gómez Román, Raúl, Tollefsen, Stig, Saville, Melanie, Mayhew, Stephen
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.05.2020
Nature Publishing Group
Subjects
Aged
Betacoronavirus - immunology
Biomedicine
Biotechnology
Cancer Research
Child
Clinical Trials, Phase I as Topic
Coronavirus Infections - genetics
Coronavirus Infections - immunology
Coronavirus Infections - prevention & control
Coronavirus Infections - virology
COVID-19
COVID-19 Vaccines
Drug Development
Drug Industry
Female
From The Analyst's Couch
from-the-analysts-couch
Genetic Vectors
Humans
Internationality
Medicinal Chemistry
Molecular Medicine
Pandemics - prevention & control
Pharmaceutical industry
Pharmacology/Toxicology
Planning
Pneumonia, Viral - immunology
Pneumonia, Viral - prevention & control
Pneumonia, Viral - virology
Pregnancy
Product development
Public health administration
SARS-CoV-2
Time Factors
Vaccines, Attenuated
Vaccines, Inactivated
Vaccines, Subunit
Vaccines, Synthetic
Viral Vaccines - administration & dosage
Viral Vaccines - chemistry
Viral Vaccines - genetics
Viral Vaccines - immunology
United States
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-News-1
content type line 66
ISSN:1474-1776
1474-1784
DOI:10.1038/d41573-020-00073-5